Laura Deming is a founding partner at The Longevity Fund. Her work focuses on human life extension and using biological research to reduce the effects of aging. Deming went to MIT at age 14 to study physics, and she eventually dropped out of to join the first class of the Thiel Fellowship in 2011. In 2018, Laura launched Age1, a four month startup accelerator program tailored for longevity companies.